Infertility with Testicular Cancer




Testicular germ cell cancer is one of the most curable cancers. Most patients are treated during their reproductive years, making infertility a significant quality of life issue after successful treatment. This focused review evaluates the factors that contribute to infertility and specific fertility risks with the various testicular cancer treatments. Timing of patient discussions and current fertility treatments are reviewed.




  • •

    A full discussion of the gonadotoxic effects of cancer treatment and the possibility of sperm or testicular tissue cryopreservation, even in adolescent and prepubertal patients, should become standard of care.




  • •

    A full discussion of the gonadotoxic effects of cancer treatment and the possibility of sperm or testicular tissue cryopreservation, even in adolescent and prepubertal patients, should become standard of care.












    • References



    1. 1. Huyghe E., Matsuda T., and Thonneau P.: Increasing incidence of testicular cancer worldwide: a review. J Urol 2003; 170: pp. 5-11

    2. 2. Spira A.: Epidemiology of human reproduction. Hum Reprod 1986; 1: pp. 111-115

    3. 3. Mosher W.D., and Pratt W.F.: Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991; 56: pp. 192-193

    4. 4. Ragni G., Somigliana E., Restelli L., et al: Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 2003; 97: pp. 1624-1629

    5. 5. Lass A., Akagbosu F., Abusheikha N., et al: A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod 1998; 13: pp. 3256

    6. 6. Bahadur G., Ozturk O., Muneer A., et al: Semen quality before and after gonadotoxic treatment. Hum Reprod 2005; 20: pp. 774

    7. 7. Williams D.H., Karpman E., Sander J.C., et al: Pretreatment semen parameters in men with cancer. J Urol 2009; 181: pp. 736-740

    8. 8. Hendry W.F., Stedronska J., Jones C.R., et al: Semen analysis in testicular cancer and Hodgkin’s disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol 1983; 55: pp. 769-773

    9. 9. Dieckmann K.P., Linke J., Pichlmeier U., et al: Spermatogenesis in the contralateral testis of patients with testicular germ cell cancer: histological evaluation of testicular biopsies and comparison with healthy males. BJU Int 2007; 99: pp. 1079-1085

    10. 10. Jacobsen R., Bostofte E., Engholm G., et al: Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000; 321: pp. 789-792

    11. 11. Walsh T.J., Croughan M.S., Schembri M., et al: Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009; 169: pp. 351-356

    12. 12. Marmor D., Elefant E., Dauchez C., et al: Semen analysis in Hodgkin’s disease before the onset of treatment. Cancer 1986; 57: pp. 1986-1987

    13. 13. Plata-Salamán C.R.: Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16: pp. 1009-1012

    14. 14. Hotaling J.M., Lopushnyan N.A., Davenport M., et al: Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril 2013; 99: pp. 464-469

    15. 15. Carroll P.R., Whitmore W.F., Herr H.W., et al: Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol 1987; 137: pp. 420-423

    16. 16. Petersen P.M., Skakkebaek N.E., Rørth M., et al: Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol 1999; 161: pp. 822-826

    17. 17. Fossa S.D., Theodorsen L., Norman N., et al: Recovery of impaired pretreatment spermatogenesis in testicular cancer. Fertil Steril 1990; 54: pp. 493-496

    18. 18. Brennemann W., Stoffel-Wagner B., Wichers M., et al: Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer. J Urol 1998; 159: pp. 1942-1946

    19. 19. Sprauten M., Brydøy M., Haugnes H.S., et al: Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. J Clin Oncol 2014; 32: pp. 571-578

    20. 20. de Bruin D., de Jong I.J., Arts E.G., et al: Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones. Fertil Steril 2009; 91: pp. 2481-2486

    21. 21. Hansen P.V., Trykker H., Andersen J., et al: Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989; 64: pp. 956-961

    22. 22. Paoli D., Gilio B., Piroli E., et al: Testicular tumors as a possible cause of antisperm autoimmune response. Fertil Steril 2009; 91: pp. 414-419

    23. 23. Guazzieri S., Lembo A., Ferro G., et al: Sperm antibody and infertility in patients with testicular cancer. Urology 1985; 26: pp. 139-142

    24. 24. Foster R.S., Rubin L.R., McNulty A., et al: Detection of antisperm- antibodies in patients with primary testicular cancer. Int J Androl 1991; 14: pp. 179-185

    25. 25. Höbarth K., Klinger H.C., Maier U., et al: Incidence of antisperm antibodies in patients with carcinoma of the testis and in subfertile men with normogonadotropic oligoasthenoteratozoospermia. Urol Int 1994; 52: pp. 162-165

    26. 26. Garner M.J., Turner M.C., Ghadirian P., et al: Epidemiology of testicular cancer: an overview. Int J Cancer 2005; 116: pp. 331-339

    27. 27. Juul A., Almstrup K., Andersson A.M., et al: Possible fetal determinants of male infertility. Nat Rev Endocrinol 2014; 10: pp. 553-562

    28. 28. Qiao D., Zeeman A.M., Deng W., et al: Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002; 21: pp. 3988-3999

    29. 29. Hotaling J.M., and Walsh T.J.: Male infertility: a risk factor for testicular cancer. Nat Rev Urol 2009; 6: pp. 550-556

    30. 30. Langenstroer P., Rosen M.A., Griebling T.L., et al: Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance–a decision analysis. J Urol 2002; 168: pp. 1396-1401

    31. 31. Carroll P.R., Morse M.J., Whitmore W.F., et al: Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol 1987; 138: pp. 70-72

    32. 32. Jacobsen K.D., Theodorsen L., and Fossa S.D.: Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy. J Urol 2001; 165: pp. 93-96

    33. 33. Brydøy M., Fosså S.D., Klepp O., et al: Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: pp. 1580-1588

    34. 34. Beck S.D., Bey A.L., Bihrle R., et al: Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol 2010; 184: pp. 2078-2080

    35. 35. Jacobsen K.D., Ous S., Waehre H., et al: Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 1999; 80: pp. 249-255

    36. 36. Shalet S.M.: Effect of irradiation treatment on gonadal function in men treated for germ cell cancer. Eur Urol 1993; 23: pp. 148-151

    37. 37. Gordon W., Siegmund K., Stanisic T.H., et al: A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys 1997 Apr 1; 38: pp. 83-94

    38. 38. Hansen P.V., Trykker H., Svennekjaer I.L., et al: Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother Oncol 1990; 18: pp. 117-125

    39. 39. Pont J., and Albrecht W.: Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 1997; 68: pp. 1-5

    40. 40. Brydøy M., Fosså S.D., Klepp O., et al: Norwegian Urology Cancer Group III study group. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 2010; 58: pp. 134-140

    41. 41. Wortel R.C., Alemayehu W.G., and Incrocci L.: Orchiectomy and radiotherapy for stage I-II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function. J Sex Med 2015; 12: pp. 210-218

    42. 42. Arai Y., Kawakita M., Okada Y., et al: Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 1997; 15: pp. 1444-1448

    43. 43. Rossen P., Pedersen A.F., Zachariae R., et al: Sexuality and body image in long-term survivors of testicular cancer. Eur J Cancer 2012; 48: pp. 571-578

    44. 44. Bloom J.R., Fobair P., Gritz E., et al: Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 1993; 11: pp. 979-988

    45. 45. Tal R., Stember D.S., Logmanieh N., et al: Erectile dysfunction in men treated for testicular cancer. BJU Int 2014; 113: pp. 907-910

    46. 46. Choy J.T., and Brannigan R.E.: The determination of reproductive safety in men during and after cancer treatment. Fertil Steril 2013; 100: pp. 1187-1191

    47. 47. Hartmann J.T., Albrecht C., Schmoll H.J., et al: Longterm effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 1999; 80: pp. 801-807

    48. 48. Nangia A.K., Krieg S.A., and Kim S.S.: Clinical guidelines for sperm cryopreservation in cancer patients. Fertil Steril 2013; 100: pp. 1203-1209

    49. 49. Choy J.T., Wiser H.J., Bell S.W., et al: Predictors of spermatogenesis in orchiectomy specimens. Urology 2013; 81: pp. 288-292

    50. 50. Schrader M., Müller M., Sofikitis N., et al: “Onco-tese”: testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines? Urology 2003; 61: pp. 421-425

    51. 51. Furuhashi K., Ishikawa T., Hashimoto H., et al: Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients. Andrologia 2013; 45: pp. 107-110

    52. 52. Haddad N., Al-Rabeeah K., Onerheim R., et al: Is ex vivo microdissection testicular sperm extraction indicated for infertile men undergoing radical orchiectomy for testicular cancer? Case report and literature review. Fertil Steril 2014; 101: pp. 956-959

    53. 53. Hsiao W., Stahl P.J., Osterberg E.C., et al: Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the weill cornell experience. J Clin Oncol 2011; 29: pp. 1607-1611

    54. 54. Nahata L., Cohen L.E., and Yu R.N.: Barriers to fertility preservation in male adolescents with cancer: it’s time for a multidisciplinary approach that includes urologists. Urology 2012; 79: pp. 1206-1209

    55. 55. Sadri-Ardekani H., Akhondi M.M., Vossough P., et al: Parental attitudes toward fertility preservation in boys with cancer: context of different risk levels of infertility and success rates of fertility restoration. Fertil Steril 2013; 99: pp. 796-802

    56. 56. Di Pietro M.L., and Teleman A.A.: Cryopreservation of testicular tissue in pediatrics: practical and ethical issues. J Matern Fetal Neonatal Med 2013; 26: pp. 1524-1527

    57. 57. Ginsberg J.P., Carlson C.A., Lin K., et al: An experimental protocol for fertility preservation in pre-pubertalboys recently diagnosed with cancer: a report of acceptability and safety. Hum Reprod 2010; 25: pp. 37-41

    58. 58. Struijk R.B., Mulder C.L., van der Veen F., et al: Restoring fertility in sterile childhood cancer survivors by autotransplanting spermatogonial stem cells: are we there yet? Biomed Res Int 2013; 2013: pp. 903142

    Only gold members can continue reading. Log In or Register to continue

    Related posts:

    Default ThumbnailEpidemiology and Diagnosis of Testis Cancer Default ThumbnailIntratubular Germ Cell Neoplasia of the Testis, Bilateral Testicular Cancer, and Aberrant Histologies Default ThumbnailManagement of Low-Stage Testicular Seminoma Default ThumbnailThe Role of Postchemotherapy Surgery in Germ Cell Tumors Default ThumbnailChemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors Default ThumbnailDesperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors

    Stay updated, free articles. Join our Telegram channel
    Tags:
    Mar 3, 2017 | Posted by in UROLOGY | Comments Off on Infertility with Testicular Cancer

    Full access? Get Clinical Tree
    Get Clinical Tree app for offline access